Literature DB >> 7619026

The frequency and associated risk factors for dementia in patients with Parkinson's disease.

K Marder1, M X Tang, L Cote, Y Stern, R Mayeux.   

Abstract

OBJECTIVES: To estimate the frequency and determine the risk factors for incident dementia in community-dwelling patients with Parkinson's disease (PD) and in control subjects.
DESIGN: Prospective cohort study. During a 3.5-year period, 140 patients with idiopathic PD without evidence of dementia and 572 nondemented control subjects were identified in the community of Washington Heights-Inwood in New York, NY. All subjects underwent neurological and neuropsychological evaluations and follow-up examinations.
RESULTS: Twenty-seven patients with PD (19.2%) became demented throughout 2 years, as compared with 87 (15.2%) of the control subjects. The relative risk (RR) for the development of dementia with PD was 1.7 (95% confidence interval [CI], 1.1 to 2.7) after adjusting for age, education, and gender. Predictive features of incident dementia were an extrapyramidal score greater than 25 (RR, 3.56; 95% CI, 1.4 to 8.9) and a Hamilton Depression Rating Scale score greater than 10 (RR, 3.55; 95% CI, 1.6 to 7.9).
CONCLUSION: Patients with PD, especially those with severe extrapyramidal signs, have almost twice the risk for the development of dementia than do community-dwelling control subjects.

Entities:  

Mesh:

Year:  1995        PMID: 7619026     DOI: 10.1001/archneur.1995.00540310069018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  54 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Depression in Parkinson's disease.

Authors:  H Allain; S Schuck; N Mauduit
Journal:  BMJ       Date:  2000-05-13

Review 3.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

4.  Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

5.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

6.  Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson's Disease: Considerations from a Pilot Study.

Authors:  Catherine C Price; Shellie-Anne Levy; Jared Tanner; Cyndi Garvan; Jade Ward; Farheen Akbar; Dawn Bowers; Mark Rice; Michael Okun
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 7.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

8.  Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.

Authors:  Roseanne D Dobkin; Alexander I Tröster; Jade Tiu Rubino; Lesley A Allen; Michael A Gara; Margery H Mark; Matthew Menza
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

9.  Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample.

Authors:  Peijun Chen; Helen C Kales; Daniel Weintraub; Frederic C Blow; Lan Jiang; Alan M Mellow
Journal:  J Geriatr Psychiatry Neurol       Date:  2007-09       Impact factor: 2.680

10.  Cognitive impairments in progression of Parkinson's disease.

Authors:  D A Stepkina; V V Zakharov; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.